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ABSTRACT 
Background: Patients with an implantable cardioverter defibrillator (ICD) retain a scar and a 
bump at the site of implant. This may lead to body image concerns (BICs) that influence 30 
patients’ quality of life. Few studies have examined the prevalence and impact of BICs post 
implant, prompting us to conduct a scoping review of the field. 
Methods: We searched the Medline, Embase, PsycINFO and Cinahl databases in August 2016 
and repeated the search May 2017. Included were patients ≥ 18 years, an ICD implant 
(transvenous, subcutaneous, or ICD with cardiac resynchronization therapy (CRT-D), 35 
reported on BICs, and published in peer-reviewed English-language journals. We excluded 
non-systematic reviews, opinion pieces/letters, case studies, conference abstracts, PhD 
dissertations, and protocol papers, studies of ICD shock treatment of atrial fibrillation, of 
abdominally or submammary implanted ICDs. 
Results: A total of 40 articles were included; 16 qualitative and 24 quantitative. None of the 40 
included studies had BICs as their primary endpoint. Results showed that BICs are present in 
various degrees in the ICD population and can be attributed to the visibility of the ICD (the 
scar and bump). Women and younger patients had greater problems with BICs, although 
men also had concerns. The two BICs items of the “Florida Patient Acceptance Survey” were 
the most frequently used.  45 
Conclusion: BICs were present among ICD patients, but the degree of impact on their lives 
varied. There is a need for developing a BICs questionnaire in order to examine the 
prevalence of BICs and the potential impact on patients’ lives.  
 
Abstract (word count): 250  50 
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INTRODUCTION 
Guidelines recommend the implantable cardioverter defibrillator (ICD) as the first line of 55 
treatment for the primary and secondary prevention of sudden cardiac death (1-3). Studies 
show that there has been an increase in ICD implantation rates until recently, with a plateau 
having been reached and some European countries even showing a decline (4). In the United 
States, the implant rate was 577 per million inhabitants in 2011 (5, 6), while the European 
Union had a total of 155 ICD implantations per million inhabitants (2013) (6, 7). 60 
 Despite the unequivocal medical benefits, ICD therapy is associated with increased risk 
of procedural and device-related complications, such as infection, lead fractures, and 
inappropriate therapies (i.e., shock therapy given in the absence of a life-threatening 
arrhythmia) (8), that may have a negative influence on patients’ well-being and quality of life 
(9).  Additionally, body image concerns due to the scar and size of the ICD under the skin are 65 
device-related issues, that may also impact patients’ well-being and quality of life (10-13). 
Nowadays, the ICD is usually implanted under the skin in the subclavicular region. This 
procedure produces a visible scar and bump under the skin due to the size of the device (13, 
14), which can lead to noticeable discomfort for some patients. As one patient stated: “The 
scar is huge and I don't wear tank tops or roll up my sleeves at all unless I'm in front of my 70 
close friends who know exactly what happened, my boyfriend or my family”. Another women 
stated: “I pick clothing that doesn't show the scars.” (15). 
 Aesthetic operation techniques which aim to hide the bump from the ICD, such as 
subpectoral placement or submammary placement have been tested in women with 
promising results (11-14, 16). However, subclavicular placement of the ICD is still standard 75 
practice, and little is known about the prevalence of body image concerns in patients with an 
ICD and the impact on patients’ lives.  
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The scarce evidence is conflicting. Some studies suggest gender differences, where women 
may be more likely to report post-implant body image concerns compared to men, in terms 
of concerns about how to make clothing fit to hide the bump from the device. Moreover, 80 
there is a risk of further scarring because of the weight of the breasts (13). Others suggest 
that women have a higher risk for developing distress due to body image issues, but that 
more research is needed (17). A recent meta-analysis (18) confirms that there is no 
consensus whether gender differences in body image concerns exist (19-22), and whether 
younger women are likely to have more concerns than older women (15, 23). 85 
 Given the scarce and conflicting evidence on the prevalence and impact of body image 
concerns, and knowing that poor patient-reported health status is an independent predictor 
of mortality in ICD patients (24-26), we performed a scoping review of the available 
literature to examine the prevalence of body image concerns and the potential impact on 
patients’ lives.  90 
 
METHODS 
Search strategy 
A first exploratory search was performed in August 2016 and repeated in May 2017. The 
electronic databases Medline, Embase, PsycINFO and Cinahl were searched for the period 95 
between January 1980 (the introduction of the first commercially available ICD device) and 
May 2017. The search terms, including “Implantable cardioverter defibrillator”, “Internal 
defibrillator”, “Defibrillators, Implantable”, "Self-Concept", “Self-Perception”, "Self-Esteem”, 
“Physical Appearance”, “Personal Appearance", “Body Awareness” and "Body Image", were 
used in various combinations, including MeSH terms and free text, with the adjacency (ADJ) 100 
operands being included in the “various combinations of search terms”. Reference lists of 
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the included articles were examined to find further relevant articles as well as grey 
literature.  
 
Study selection 105 
Inclusion and exclusion criteria 
Qualitative and quantitative studies were included, if they fulfilled the following criteria: (1) 
described patients ≥ 18 years with implantation of a transvenous ICD or subcutaneous ICD or 
ICD with cardiac resynchronization therapy (CRT-D), (2) body image concerns were reported 
in the results, and (3) published in peer-reviewed English-language journals. We excluded (1) 110 
non-systematic reviews, opinion pieces/letters, case studies, conference abstracts, PhD 
dissertations, and protocol papers, (2) studies of ICD-AT (ICD shock treatment of atrial 
fibrillation), (3) studies on patients with abdominally implanted ICDs (as this implantation 
technique is no longer carried out) and (4) submammary implanted ICDs (as this technique is 
new).  115 
 
Search outcomes  
A total of 3,844 articles were identified. After eliminating duplicates, a total of 3,302 articles 
were screened, using the tool Covidence for Windows version 2017 (27). A refined and 
updated search was conducted in May 2017, yielding an additional 112 articles to screen 120 
after removing duplicates. Furthermore, one article was identified from the reference lists of 
included papers and inserted into Covidence. At first, a title/abstract screening was carried 
out individually by two reviewers (SJS and VSF), resulting in a total of 144 papers that were 
assessed for full text eligibility. In case of disagreement whether to include in the review, SJS 
and VSF carried out a full text screening. If the two authors could not reach a consensus, the 125 
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conflict was resolved by consulting a third reviewer (SSP or RNK). After full-text screening, 
104 studies were excluded. Finally, a total of 40 articles were included after reading full text; 
16 qualitative and 24 quantitative articles. For an overview of the search process, see the 
PRISMA flowchart (Figure 1). 
 130 
Data items and collection process  
We included both qualitative and quantitative articles in this scoping review. An overview of 
the qualitative studies is listed in Table 1, while Table 2 presents an overview of the 
quantitative studies.   
 135 
Assessment of study quality 
The rationale for this scoping review was to provide a broader overview of the literature on 
body image concerns in patients with an ICD. Therefore, we included both qualitative and 
quantitative studies. There is no consensus in the literature whether a scoping review should 
contain a quality assessment (28, 29). Due to the present lack of consensus about assessing 140 
quality in qualitative studies (30-32), we decided not to assess the methodological quality.  
None of the quantitative studies had body image concerns as their primary focus. We 
therefore decided not to perform a quality assessment, as this would yield very little usable 
context to evaluate the studies (28). 
 145 
RESULTS 
Qualitative findings 
Description of samples 
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Table 1 show 15 of the 16 qualitative studies that we included in the scoping review. We 
found one systematic review that included qualitative studies (18). We excluded this review 150 
as all the qualitative studies were already listed in Table 1. One of the studies also focused 
on family members, but only the results on patients are included (33). The studies were 
published between 1991 and 2016. A total of 294 patients with an ICD were included (range 
3-54).  
The interviews were conducted as individual interviews in the majority of the studies 155 
(in person or by telephone), although some studies used both focus group interviews and 
individual interviews (34, 35). Time of patient enrolment differed across studies. Some 
studies enrolled ICD patients directly after implantation, where others identified patients 
from their outpatient clinics, recruitment brochures or from the internet. Time of interview 
also varied greatly, with recruited patients being interviewed anywhere from immediately 160 
after implantation up to 24 years after. 
Age across studies ranged from 18 to 80 years. The reported mean age ranged from 
23.7 to 63.7 years – however, mean age was not reported in all studies (e.g., (36-38). The 
majority of patients were male (range 40-90.9%), and one study only reported that the 
‘typical subject’ was male with no supporting statistics (37), and one study included only 165 
women (36).  
 
Patients’ experiences with an ICD 
The ICD recipients express an awareness of the ICD components inside their body. They feel 
the physical presence of the ICD, see it, or are aware of it because other people notice it. 170 
However, these sensations seem to decrease over time. This awareness leads to feelings 
reported as intrusive that serve as a constant reminder of the ICD: “Yeah, I mean just being 
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that it is there and it should not be there and it shows itself all the time. I especially know it's 
there in the summer when you wear fewer clothes, especially bathing suits. To me it is 
constant reminder that I may feel fine, but I am technically sick” (36).   175 
 
Visibility  
The visibility of the scarring and the visible shape of the device give rise to feelings, in both 
men and women, of looking different, feeling disfigured, being uncomfortable and feeling 
embarrassed. Wearing swimsuits, shirtless or strapless dresses, feeling uncomfortable 180 
swimming in public, removing their shirts, or wearing clothing which leaves the ICD site 
exposed causes feelings of insecurity and awkwardness: “It looks like a pack of cards sticking 
out. They can see it over my clothes” (33). “I also feel uncomfortable when I see the implant 
area” (39). The ICD recipients report insecurity about their physical appearance both among 
their family, friends and peers but also in personal relationships. Body image and scarring 185 
can also interfere with intimacy: “If someone leans against me and puts their head on my 
chest, it’s uncomfortable” (40). 
 
Appearance 
It is not clear whether all ICD recipients become accustomed to the appearance of their 190 
bodies after the ICD implantation. Some have continued problems with body image: “I also 
feel uncomfortable when I see the implant area. I worry that these feelings have continued 
throughout my recovery” (39). Others embrace their device and have no problems, showing 
their body, the scarring and lump, sometimes even proudly so: “I don’t try and cover it up at 
all, it’s part of who I am. I’ll take anyone’s hand, they’ll say ‘what’s that lump’ and I say ‘feel 195 
it, you can touch it” (10).   
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Quantitative findings 
Description of samples 
Table 2 shows the 24 quantitative studies included in the scoping review. In all studies, body 200 
image concerns were reported as a secondary outcome.  
 The studies were published between 1990 and 2015. A total of N= 3,173 patients 
with an ICD were included (range N = 16-566). However, the total number of included 
patients in Table 2  is 3,618, as some of the studies also included other patient groups with 
e.g. pacemakers (PM) and ICD-AT (41), a combination of pacemakers and other implantable 205 
devices (42), and pacemakers (43, 44) and spouses (45).  
 Time of patient enrolment differed across studies. Some studies enrolled ICD patients 
directly after implantation, via registries, one study because of a world-wide advisory on 
specially manufactured ICDs that experienced rapid battery depletion (46), or via the 
internet, while others identified patients from their outpatient clinics / medical centers at 210 
follow-up. Patients were recruited in a time range of post-implantation up to 21 years after 
implantation. 
Age across studies ranged from 13 to 98 years, however, age range was not reported in all 
studies (20-23, 41, 43, 46-53). The reported mean age ranged from 21.2 to 78 years, 
although the mean age was not reported in two studies (53, 54). The studies included both 215 
men and women; mostly patients were male (range 43.8% - 90.0%), except from one study 
that included only women (22). Most of the studies used a cross sectional design except 
from four prospective studies (20, 23, 54, 55) and one observational longitudinal study (53). 
 
 220 
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Questionnaires identified 
The literature revealed the following questionnaires which contained items tapping into 
body image concerns (Table 3): the “Florida Patient Acceptance Survey/Scale” (FPAS) (20-22, 
41, 46-48, 50, 51, 56, 57), the “Brodsky ICD Questionnaire” (54, 55), the “Implanted Device 
Adjustment Scale” (IDAS) (42, 44), “Low Treatment Satisfaction” (LTS) (49), the “Cleveland 225 
Clinic AICD Psychosocial Inventory” (45), the “Index of Subjective Concerns for People with 
ICDs” (ISCP-ICD), and the “Worries about ICD WAICD Scale” (WAICD) (52). There was also 
one study that used an “unspecified modification of the SF-36 questionnaire” (58) and five 
studies that used purpose-designed questionnaires (23, 43, 53, 59, 60). 
 230 
Gender and age 
There was a trend for gender differences, with women reporting more body image concerns 
than men (20, 23, 42, 52, 58), however one study found no gender differences (47). Younger 
age was associated with more body image concerns (22, 23, 56). One study found an 
association between older age and higher device acceptance (21). However, another study 235 
found that women worried more than men about their appearance after receiving an ICD, 
with their scores remaining constant over time (23), while a third study showed that worries 
about body appearance, in both men and women, did not decrease with time (53). One 
study reported ethnic differences with Afro-American women having more concerns than 
Caucasian women (57). 240 
 
Types of body image concerns 
The most frequent body image concern reported was the size of the ICD, which caused 
changes of the body’s form and noticeability of the device (49, 55, 59), self-consciousness 
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and apprehension about touching or looking at the implantations area (45). In one study, the 245 
majority deemed the appearance of the scar or bump acceptable, however, almost half of 
the patients admitted to covering up the wound or had negative opinions on the scar, or felt 
shame being intimate or undressed (60). One study reported that patients scoring high on 
Type D  personality were more likely to report body image concerns (51) while another study 
did not find an association (20). Some studies did not observe body image concerns in their 250 
group comparisons, e.g., ICD-Congenital versus ICD-non-Congenital (46, 47). One study’s 
main focus was development of a questionnaire the “Implanted Device Adjustment Scale” 
(IDAS) and did not report results on body image concerns (44). One study found that ICD 
patients had more concerns than pacemaker (PM) patients (41), while another study 
reported some level of body image concerns among the participants but with no significant 255 
differences between PM and ICD patients (43). One study reported body image concerns 
among secondary prevention patients when compared to primary prevention patients (48). 
Another study found that patients reporting more body image concerns would consider 
replacement of the ICD as compared to those that did not consider replacement of the ICD 
(50).  260 
 
DISCUSSION 
The purpose of the current study was to examine the prevalence of body image concerns in 
patients with an ICD and the potential impact on patients’ lives. Given the scarce and 
conflicting evidence, we performed a scoping review (28, 29) rather than a systematic review 265 
of the available literature and allowed both for the inclusion of quantitative as well as 
qualitative studies. We identified 16 qualitative and 24 quantitative studies that focused on 
body image concerns and their potential impact on patients’ lives. Qualitative studies 
14 
 
provide a more in-depth and detailed exploration of the individual patient’s experience and 
comprise an important source of information in particular with respect to informing future 270 
research in fields that are underdeveloped (61) as the included qualitative studies in relation 
to body image concerns (10, 15, 18, 33-40, 62-66). 
 Most of the included quantitative studies were cross-sectional (21, 22, 41-52, 56-60) 
and therefore, it was not possible to determine whether body image concerns change over 
time. None of the included studies used body image concerns as their primary outcome. In 275 
addition, information about body image concerns was sometimes scarce and mostly found in 
the text / tables. In most cases, information was also reported with insufficient clarity to 
extract data on e.g., the content of the scales used and their psychometric properties and it 
was often impossible to retrieve the questionnaires being discussed, as many of them had 
not been formally published (e.g., a “Unspecified modification of SF 36 questionnaire” (58); a 280 
“Unspecified purpose-designed questionnaire” (59); the “Low Treatment Satisfaction 
questionnaire” (49); the “Cleveland Clinic AICD Psychosocial Inventory questionnaire” (45);  a 
“Purpose designed questionnaire” (60); the “Brodsky ICD Questionnaire” (54, 55), the “ICD 
Quality of Life questionnaire”(53) and the “ICD specific questionnaire” (23).  
 Some of the quantitative studies used purpose-designed questionnaires (43, 59, 60), 285 
which among other things tapped into body image concerns. Other studies used validated 
questionnaires as the FPAS (20-22, 41, 46-48, 50, 51, 56, 57), and the IDAS (42, 44); however 
mostly there were only one or two questions tapping into body image concerns and often 
just a total sum score was reported. The most commonly used questionnaire was the 
“Florida Patient Acceptance Survey” (FPAS), which has only 2 items that tap into body image 290 
concerns (41). We did not provide a quality assessment of the individual studies (28) as this 
is a scoping review. In addition, given that none of the studies focused on body image 
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concerns as the primary outcome and the lack of systematic use of questionnaires that are 
standardized and validated and specifically designed to tap into body image concerns, it was 
not possible to determine the true prevalence of body image concerns in the ICD population. 295 
Taken together, these findings show that that there is no good and standardized 
questionnaires that tap into body image concerns for ICD patients and that there is a need to 
develop a new one. 
 It is known that the massive media exposure with body image ideals affects men and 
women and gives rise to body image concerns (67, 68). In this review, there was a trend in 300 
the majority of the studies to report on young women with body image concerns rather than 
men; however some studies also showed body image concerns among men. Some studies 
found that older age at implantation was associated with fewer concerns, where others 
showed that concerns did not decrease with increasing age. With respect to gender 
differences, it has been proposed that women are more likely to report body image concerns 305 
post implantation due to the scar as compared to men (13), which we also found in this 
scoping review.  
 Apart from reporting more body image concerns among women, previous studies have 
shown that women with an ICD may be more vulnerable for experiencing reduced quality of 
life than men (9), and may therefore be more vulnerable for developing depression as the 310 
two are related (69). However, evidence for this was mixed in this scoping review (21, 23, 
70-75), probably due to comparable mixed effects in gender differences. 
 Our results showed that experiences of embarrassment due to altered body image (a 
visible scar and bump under the skin) could have an impact on patient’s social lives. The 
connection with body image concerns and psychosocial issues has also been shown to be 315 
evident in other patient populations and importantly that it is not related to the severity of 
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the disfigurement (69). Hence this factor is an important finding, as studies show that 
mental health, symptoms of anxiety and depression are independent factors that increases 
the risk of ventricular tachyarrhythmia’s and mortality (76) as well as noncompliance with 
medical treatment (77).  320 
 
Clinical implications 
The results of this scoping review showed, that some ICD patients are affected by body 
image concerns. Given the available evidence it is difficult to determine whether body image 
concerns are more prevalent in women or in men. Nowadays standard implantation site of 325 
the ICD is at the subclavicular area, leaving the scar / bump visible. Intramuscular 
implantation still leaves a scar, but not a visible bump (78). It is known that an individualistic 
and holistic involvement and communication with patients from the health care 
professionals plays a crucial role for patient’s satisfaction with the healthcare system and 
treatment (79). Discussions about implantation site and offering of an alternative 330 
implantation area should therefore be offered to all ICD patients. The importance of patient 
involvement in this decision is crucial in terms of avoiding psychosocial issues. Novel studies 
have revealed a new submammary implantation technique that leaves patients satisfied in 
terms of body image concerns (11, 12, 14) however this requires an adoption of the method 
by the clinicians, as this is currently not the standard implantation technique for ICDs.  335 
 
Limitations 
The results of this scoping review have some limitations and need to be interpreted with 
some caution. Firstly, the results may be subject to bias, as body image concerns was not the 
primary outcome in the included studies, which resulted in a limited amount of information 340 
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on body image concerns in the primary papers. Second, a potential selection bias could be 
present as we only included papers published in the English language.  
 
Future research 
As we know that even relatively small disfigurements can have a large impact on 345 
psychosocial outcomes (69), more research on the link between body image concerns and 
psychosocial outcomes is warranted. More long-term research could help detecting changes 
in body image concerns and potential gender differences in ICD patients. We found that the 
most frequently used questionnaire in this scoping review was the FPAS (41), however, the 
FPAS has only two items measuring body image concerns which precludes any psychometric 350 
analyses. Based on the current scoping review, the use of a questionnaire with more items 
specially tapping into body image concerns appears to be a more convincing predictor of the 
prevalence and impact on patients’ lives than a generic questionnaire.  There is a knowledge 
gap with regard to assessment tools of body image concerns in ICD patients and further 
research is warranted to create a more comprehensive scale tapping into body image 355 
concerns. To entail more thorough information about body image concerns, the use of 
mixed-methods could be a recommendation for future research. Using a participatory 
design, involving both patients and health care professionals (80) could be a method to 
develop a more specific questionnaire tapping into body image concerns. Furthermore, 
there is an urgent need for prospective studies with long-term follow-up in order to 360 
determine whether patients adapt to the scar / bump at the site of implant, whether subsets 
of patients (e.g. younger and female patients) are at greater risk of developing body image 
concerns and, whether the impact of these concerns on patients’ well-being and quality of 
life varies across patients. 
18 
 
 365 
CONCLUSION 
Body image concerns were prevalent among ICD patients however the degree of impact on 
their lives varied. The studies in this review did not investigate body image concerns as their 
primary endpoint. Future research is warranted in terms to explore the prevalence of body 
image concerns and the potential impact on patients’ lives.  370 
 
 
 
 
 375 
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 Reference  Participants 
N (% men) 
 
Age (years) Time since 
implantation 
Design (interview time points 
post-implantation) 
Results  (Impact of body image concerns) 
1 Burke 
(1996) (62) 
N = 24  
(58% men) 
 
Mean (SD) age: 
59 (-) years. 
 
Range: 
22-78 years 
Up to 6 months. Qualitative study. 
 
Interviews at baseline, at 3 and 
6 months.  
 
Physical sensations were about awareness of the ICD inside the 
body which decreased over time in most of the patients. The 
associated emotions were reported as intrusive: “First week: Of 
looking different”. “Three months: Of feeling disfigured”. 
2 Cinar 
(2013) (63) 
Experimental 
group:  
N=27 
(78% men) 
 
Control group: 
N=27  
(82% men) 
 
Experimental 
group: 
Mean (SD) age: 
63.41(11.37) years 
 
Range: 
- 
Control group:  
Mean (SD) age: 
6 months and 
less : 
E:17 (63.0) 
C: 15 (55.6) 
≥7 months: 
E: 10 (37.0) 
C: 12 (44.4) 
Mixed-methods study.  
Experimental group: 
A total of 4 semi-structured 
interviews: 
• Baseline; 15 days 
(education); 3 months 
(same education); 6 
months. 
 
In the months following the implantation, some of the patients 
were accustomed to the appearance of their body and 
maintained normal activities. 
 
 
 
 
 
Table 1: Overview of qualitative studies – body image concerns 
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63.74(11.00) years 
Range: 
- 
Control group: 
A total of 2 interviews: 
• Baseline; 6 months. 
3 Conelius 
(2015) (36) 
N = 3 
(0% men) 
 
Mean (SD) age: 
- 
Range:                  
34-50 years 
 
More than 1 
year 
Qualitative descriptive 
phenomenology study  
 
Individual interviews  
 
Timepoint:  
- 
The women reported that they were continually reminded of 
the presence of their ICD. Although the actual incision was 
“hardly noticeable”, all women felt that the ICD was a constant 
reminder, either directly (awareness of its presence, feeling or 
seeing it physically present) or indirectly (through family 
members noticing it, or physically coming into contact with it). 
 
4 Dougherty 
(2000) (33)1 
N = 15 sudden 
cardiac arrest 
survivors. 
(86.7% men) 
 
&  
One of their family 
Mean (SD) age: 
57(11) years 
 
Range:  
31-72 years 
 
Family members: 
0-12 months Qualitative study. 
Grounded theory. 
Semi-structured interviews: 
• Hospitalization, 1, 3, 6 
and 12 months 
 
First the ICD gave rise to discomfort: “This box is finding a place 
of rest in me, and there’s an irritation where the box is stuck in 
the muscles”. 
“It looks like a pack of cards sticking out. They can see it over 
my clothes”. 
 
Patients were also fighting with impatience and getting “back 
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members: 
(86.7% men) 
Mean (SD) age: 
53(9) years. 
 
Range:  
31-72 years 
to normal”. 
 
 
5 Flemme 
(2011) (64) 
N = 16   
(56.25% men) 
 
Mean (SD) age: 
57.6(13.6) years 
 
Range:  
31-78 years 
6-24 months. 
 
Qualitative study. 
Grounded theory approach. 
Interviews by telephone or in 
the informant’s home. 
 
Timepoint:  
After 6-24 months 
The bulge and scar from the ICD implantation was something 
the ICD recipients had to accept: “The device is visible. I found it 
really hard to wear something sleeveless in the beginning, but 
now I don’t care, it’s kind of part of me…” (Woman aged 48 
years).  
 
 
 
 
6 Fridlund 
(2000) (65) 
N = 15 
(66.6% men) 
 
Mean (SD) age: 
61.8 (-) years 
 
Range: 
Mean time: 
33 months 
  
Range: 
Qualitative study. 
Holistic perspective, 
Phenomenography. 
 
Body image concerns and their ICD feeling as an intrusion were 
emphasized but also that they are sometimes able to forget 
that they had an ICD: “I don't like it. Sometimes I forget about 
it and then I'm glad that I've succeeded in forgetting about it”. 
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33-76 years 23-55 months Open and semistructured 
interviews. 
 
Timepoint: 
- 
“An alien thing has entered my body”. “It's the fact that it's 
something alien that disturbs me sometimes, but I forget about 
it when I'm together with other people”.  
7 Hallas 
(2010) (66) 
N = 13 
(76.9% men) 
 
 
Mean (SD) age:           
58.46 (13.65) years 
 
Range: 
35-80 years 
 
6 months to 5 
years. 
Qualitative study.  
 
Semi-structured interviews.  
 
Timepoint: 
- 
The majority of patients had a negative perception of their 
body due to the scar at the implant site. The primary feeling 
was embarrassment.  
 
8 Hauptman 
(2013) (34) 
N =41 
(48.8% men) 
 
 
Mean (SD) age: 
61.4 (14.7) years 
Range: 
- 
- 
 
 
Qualitative study. 
 
First eight patient focus group 
interviews were conducted. 
Timepoint: 
- 
The prevalent perception of body image was negative due to 
the cosmetic changes associated with the ICD. Body discomfort 
including “pulling sensations” and discomfort when “lying on 
the side” might have contributed to this negative perception. 
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9 Humphreys 
(2016) (10) 
N = 18 
13 non-shock 
participants 
(53.8% men) 
5 shock 
participants 
(80% men)  
Mean (SD) age: 
55.7 (-) years.  
Range:                    
28 – 68 years 
 
3-24 months. Qualitative study. 
Semi-structured interviews. 
Individually conducted. 
Timepoint: 
- 
Most patients were physically aware of the device inside their 
bodies, and some described it as a physical obstacle: “…. its 
‘incredulous’ size once implanted”.  
 
Others mentioned that they were unprepared of its protrusion: 
“…was clearly visible under the skin and some complained that 
the arm adjacent to the implant was painful with restricted 
movement”. 
 
A female non-shock patient embraced her device and proudly 
showed its protrusion. The participant wore a t-shirt which 
clearly revealed the device: “I don’t try and cover it up at all it’s 
part of who I am. I’ll take anyone’s hand, they’ll say ‘what’s 
that lump’ and I say ‘feel it, you can touch it’.”  
10 Kuiper 
(1991)(37) 
N = 20 
(- % men) 
 
Mean (SD) age: 
- 
Range:                  
39-75 year 
1 -12 months. 
Mean (SD): 
8.75(5) months  
Mixed-method 
A quantitative instrument (JC: 
Jaloweic Coping Scale)  
and  
Based on the content analysis of the semi-structured aspects as 
clothing adjustments and appearance were mentioned.  
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a semi-structured interview 
guide. 
Timepoint: 
- 
11 Larimer 
(2016) (40)2 
N = 6 
(50% men) 
 
Mean (SD) age: 
23.7 (-) years. 
 
Range:  
18- 28 years 
 
15 months to 24 
years. 
Descriptive qualitative research 
design  
 
Purposive sampling.  
In-person interview.  
Semi-structured interviews.  
 
Timepoint: 
- 
The participants had challenges in terms of insecurity about 
their physical appearance. Embarrassment arose due to the 
attention their family, friends and peers had to the visibility 
and scar from the implantation. The visibility of the ICD was 
obvious when wearing a swimsuit and clothes that either was 
shirtless or strapless. This can interfere with interpersonal 
relationships, intimacy and closeness.  
12 McDonough 
(2009) (15) 
N = 20  
(40% men). 
Telephone group: 
N =6 
(33.3% men) 
Total group: 
Mean (SD) age: 
33.5 (6.7) years. 
 
Range: 
Post ICD 
implantation. 
 
Mean (SD) 
years: 
Qualitative study. 
Interviews (telephone and 
Internet) 
Interview guide with open 
ended questions. 
All expressed body image concerns. Leaving the ICD site 
exposed made the participants feeling uncomfortable as in 
situations like swimming, not having their shirt on or clothes 
that revealed the ICD. Some felt that others would look at 
them differently, but this dissipated within a few months. 
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Internet group:  
N= 14 
(42.9% men) 
 
 
21-40 years 
 
Telephone group: 
Mean (SD) age: 
35.2(7.4) years 
Range: 
21-40 years 
 
Internet group: 
Mean (SD) age: 
32.9(6.4) years. 
Range: 
21-40 years. 
3,9 (-) years 
 
Range: 
3 months – 17 
years (only one 
for 17 years) 
 
Timepoint: 
- 
Women tended to choose clothing that covered the ICD site.  
  
 
 
 
 
 
 
 
 
 
 
 
13 Mert    
(2012) (35) 
 
  
N = 19 
(78.9% men) 
  
Mean (SD) age: 
53.57 (13.44) years 
Range: 
- 
15.47(9.82) 
months.  
 
Qualitative descriptive 
approach. 
4 focus-group interviews with 
groups of 4-5 patients. 
Semi-structured interviews 
Among the most frequently reported emotional change due to 
the ICD were changes in body image. 
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with open ended questions. 
 
Timepoint: 
- 
14 Saito 
(2012) (39) 
 
 
N = 22 
(90.9% men)  
Mean (SD) age: 
61.26 (13.4) years 
Range:                    
35-79 years. 
14 months Qualitative descriptive study. 
Semi-structured interviews. 
 
Timepoint: 
14 months 
Patients were aware of the physical existence of the ICD, 
leading to physical discomfort. Being confronted with the ICD 
area also caused discomfort. 
15 Tagney 
(2003) (38)  
 
N = 8 
(75% men) 
 
 
Mean (SD) age: 
- 
 
Range: 
36-75 years 
5-20 months Qualitative study. 
 
Semi-structured interview 
 
Timepoint: 
- 
Some adjustment concerns seemed to be associated with body 
image for patients having their ICD implanted a year or more 
earlier. Both men and women had concerns about altered 
appearance 
 400 
1: The ICD could be implanted abdominal or under the shoulder. Both sudden cardiac arrest survivors and a family member were interviewed. 
2:  All participants had PMs and 3 had PM/ICD’s.  
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 Reference Participants 
N (% men) 
 
Response 
rate 
%(send/ 
responded) 
Age Time since 
implantation 
Design Instrument 
(Total # items /  
# items on body 
image concerns) 
Key findings with respect to body 
image concerns (BIC) 
CROSS SECTIONAL 
1 Bedair1 
(2015)(47) 
N=193 
(56.5% men) 
 
147 ACHD 
Hereof  
59 ICD patients 
with congenital 
disease (59.2 % 
men) 
& 
46 non-ACHD: 
Hereof  
61.0% 
(319/193) 
 
 
Mean (SD) age:  
45.0(14.7) years 
Range: 
- 
 
Patients with 
congenital 
disease: 
 5.7 (6.1) years 
 
Patients with 
non-congenital 
disease: 
5.1 (4.8) years 
Cross 
sectional 
FPAS (18/2)   BIC 
Median (interquartile range) 
 
ICD-Congenital: 
25 (0, 50) 
 
ICD-Non-Congenital: 
0 (0, 25)  
 
There was no body image concerns 
observed between groups. 
 
Table 2:  Overview of quantitative studies – body image 
concernsQUANTIITATIVE STUDIES – BODY IMAGE CONCERNS 
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34 ICD patients 
with non-
congenital disease 
(73.9% men)  
2 Beery  
(2005)(44)2  
N=45 
(66.7% men) 
 
Hereof  
Pacemaker = 18 
ICD = 27 
97.8% 
(45/44)  
Test-retest 
after 2 
weeks:             
95.6% 
(45/43) 
Mean (SD) age: 
67.0(7) years 
Range: 
30 - 98 years 
Mean (SD) years: 
6.29(7) years  
 
Range: 
1 – 11 years  
Cross 
sectional 
+ test 
re-test 
validation 
IDAS  
(Implanted Device 
Adjustment Scale) 
(20/2) 
 
This study focused on the development 
of the IDAS. The IDAS contains two items 
tapping into body image concerns. No 
results are reported on the patients’ 
endorsements on these items.  
 
 
 
3 Beery  
(2007)(42)3  
N=173  
ICD=102 
(83.3% men in the 
ICD sample) 
 
 
- (-/173) For the whole 
sample: 
Mean (SD) age:  
69 (-) years 
Range: 
35-91.  
Mean (SD) years: 
4.3 years (3.8) 
years  
Range: 
3 months to 21 
years. 
Cross 
sectional 
IDAS  
(Implanted Devices 
Adjustment Scale) 
(21/2) 
  
 
On the body awareness subscale women 
scored significantly higher: 
Body awareness mean(SD):  
Women 6.53 (2.8) 
Men 5.48 (1.8) 
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4 Birnie 
(2009)(46) 
N (total group)=180 
 
Advisory group: 
N= 86 
(83.6% men) 
 
Non-advisory 
group: 
N= 94 
(76.6% men) 
 
 
70.3 % 
(256/180) 
  
Advisory 
group: 
70.5% 
(86/122) 
 
Non-
advisory 
group: 
70.1% 
(94/134) 
Advisory group: 
Mean (SD) age:  
67.7(9.75) years.  
 
Non-advisory 
group: 
Mean (SD) age:  
65.0(11.8) years. 
 
Range: 
- 
 
Mean (SD) 
months: 
 
Advisory group: 
52.4(9.0) months 
 
Non-advisory 
group: 
50.6(13.3) 
months 
 
P-value 0.29 
Cross 
sectional 
FPAS (18/2) FPAS scores in body image concerns: 
Advisory group: 
13.11(23.68) 
 
Non-advisory group: 
17.95(26.60) 
(no significant between-group 
differences) 
 
Multivariate analysis of correlates of 
FPAS Body image concerns with 
demographic or clinical variables did not 
find significant correlations. 
5 Burns 
(2005)(41)4 
N=238 
ICD= 58 
(66.7% male) 
 
 
72% 
(238/338) 
ICD group:  
Mean (SD) age: 
72.0 (9.6) years. 
Range: 
- 
At least 3 months Cross 
sectional 
FPAS (18/2) ICD patients had lower scores than 
pacemaker patients. Mean FPAS score: 
(76.0 – 85.4) 
P<0.001 
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6 Dubin  
(1996)(58)5  
N=16 
(43.75% men) 
88% (16/18) Time of age at 
implantation: 
The 25 implanted 
patients: 
Mean (SD) age: 
28( 8.7) years 
Range: 
13-40 years 
Assessment: 
3.3 (1.5) years 
after ICD 
implantation 
Cross-
sectional 
 
 
Unspecified 
modification of 
SF36 
Perceived attractiveness was not an 
issue for patients, however, a majority 
of patients reported issues with clothing 
and specifically with bathing wear 
(mostly women). 
 
 
 
 
 
 
 
7 Duru 
(2001)(43) 
N=152 
Pacemaker group: 
N=76  
(65.58% men) 
 
ICD total group: 
N total =210 
Pacemaker: 
(n = 124)  
ICD: 
(n = 86) 
 
Mean (SD) age. 
ICD no shock 
group: 
56.2 (12.8) years. 
 
ICD shock group: 
Time since 
implantation was: 
Pacemaker group: 
3.1 years. 
ICD group: 2.3 
years. 
Cross 
sectional 
Purpose-designed 
device 
questionnaire. 
(23/2) 
 
 
All patients reported some level of body 
image concerns, but there were no 
significant differences between 
pacemaker patients and ICD patients 
who had and had not received shocks.  
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N=76 
(84.21% men)  
 
ICD no shock group: 
N= 31 
(87.01% men) 
 
ICD shock group: 
N= 45 
(82.22% men) 
Response 
rate: 
Pacemaker 
61.3% 
(76/124) 
 
ICD 
88.4% 
(76/86) 
59.7 (13.0) years 
 
Range: 
- 
 
 
P< 0.05  
8 Groeneveld  
(2007)(48) 
N=120 
(73% men)  
 
Primary prevention: 
N= 45 
(62% men) 
Secondary 
prevention: 
100% 
(120/120) 
Mean (SD) age: 
Total group: 
60 (15) years. 
 
Primary 
prevention: 
58 (16) years. 
 
Patients receiving 
ICDs for 
secondary 
prevention of SCD 
had a longer time 
since 
implantation 
(median duration 
Cross 
sectional 
FPAS (18/2) Overall, ICD recipients reported little 
distress or body image concerns. 
Secondary prevention patients reported 
more concerns about body image, but 
this difference was not significant. 
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N= 75 
(80% men) 
Secondary 
prevention: 
61 (15) years.  
 
Range: 
- 
 
3 years vs 1 year, 
P < 0.0001) 
9 Heller 
(1998)(59) 
N=58  (72% men) 
 
43% 
(58/135) 
Mean (SD) age: 
64 (11) years 
 
Range 37-84 
years 
20 (14) months  Cross 
sectional 
 
 
 
Unspecified 
purpose- designed 
questionnaire 
 
Patients (33 %) reported worrying about 
the size of the ICD. 
Less worry about ICD size was associated 
with high levels of satisfaction with the 
ICD (Spearman’s R = 0.38; P = 0.007). 
10 James6 
(2012)(56) 
US 
N=86 
(44.19 % men) 
- % (-/-) Mean (SD) age: 
45.8(12.9) years  
 
Range: 
18-79 years 
Median: 
3.2 years 
 
Range: 
0.2 -20.1 years 
Cross 
sectional 
FPAS (18/2) Body image concerns subscale  
Mean (SD): 
17.9 (23.5) 
 
The subscale body image concerns were 
most sensitive to differences in age. 
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Younger individuals (the youngest 
quartile 35 or younger) had a 
significantly worse mean score on this 
measure (30.1 versus 13.7) than the 
older population  
11 Ladwig  
(2005)(49)7  
N=195,  
(83,6 % men)  
 
91.5% 
(195/213) 
Mean (SD) age: 
59.8 (12.6) years 
Range: 
- 
 
Months (SD): 
28.2 (21.9) 
Cross 
sectional 
Low satisfaction 
with ICD treatment 
items. 
• ICD feels like 
a foreign 
body 
• Disturbed by 
changes of 
body form 
Complaints of a dissociated perception 
(“ICD feels like a foreign body”) in 30.3% 
of the patients. 
Complaints of (“Disturbed by changes of 
body form”) in approximately 18 % of 
the patients (estimated from Figure 2). 
 
12 Lewis 
(2014)(50) 
N=106 
(75.47 % men) 
Would consider 
non replacement 
72% 
(106/147) 
Mean (SD) age: 
 
Would consider 
non replacement 
Mean (SD) years: 
 
Would consider 
non replacement 
Cross 
sectional 
FPAS (18/2) Patients who would consider 
replacement of their ICD had a higher 
score on BIC (= less acceptance) than 
those that the Non replacement cohort. 
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cohort: 
N= 15 
(60 % men). 
Would consider 
replacement 
cohort: 
N=91 
(78 % men). 
 
P-value: 0.13 
cohort: 
61.1 (16.8) years. 
   
Would consider 
replacement 
cohort:  
68.0 (12.3) years. 
 
P-value: 0.06 
 
Range: 
- 
cohort: 
9.3 (3.5)  
 
Would consider 
replacement 
cohort: 
9.1 (3.4) 
 
P-value: 0.88 
  
Would consider replacement cohort: 
Mean (SD) years: 
88.7 (22.9) 
 
Would consider non replacement 
cohort: 
Mean (SD) years: 
73.3 (34.7) 
 
P = 0.03 
13 Pedersen 
(2008)(51) 
N=566 
(82.2 % men) 
 
86.3% 
(624/723) 
Mean (SD) age: 
61.9(14.3) years 
 
Range: 
- 
 
Mean (SD) years: 
4.7(3.3) years 
Cross- 
sectional 
FPAS (18/2). No information was provided on the 
mean score on body image concerns for 
the total group but only stratified by 
Type D personality.  Type D patients 
were more likely to report body image 
concerns as compared to non-type D 
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patients: 
 
Type D patients: 
Mean (SD): 
29.86 (29.84)  
Non-Type D patients 
10.62 (21.86) 
P < 0.001)  
14 Pycha 
(1990)(45) 
N=42 
(90 % men) 
60.9% 
(42/69) 
Mean (SD) age:  
57.7(-) years 
Range: 
34-76 years  
 
Mean (SD) 
months: 
17.6 (-) months 
Range: 
1-52 months 
Cross-
sectional 
The Cleveland Clinic 
AICD Psychosocial 
Inventory 
 
 
 
 
83.3% of patients reported a successful 
incorporation of the ICD into their body 
image. However, altered body 
perceptions were also frequently 
reported. One-third of patients felt self-
conscious and some were apprehensive 
about touching or looking at themselves 
in the area where the ICD was 
implanted. 
15 Rahmawati N=179 - % (-/-) Mean (SD) age: - Cross Worries about ICD Females reported higher body image 
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(2013)(52) (81 % men) 
 
60.5 (15.9) years 
 
Range: 
- 
 
sectional (WAICD) scale. 
26/2 
 
concerns than men. However, body 
image concerns were not the most 
important worries the about ICD in this 
sample.  
 
WAICD Scores  
Mean (SD): 
Female: 40.6 (18.6) 
Male: 31.0 (18.8) 
P < 0.05 
16 Spindler 
(2009)(21) 
 
N =535. 
(81.9% men). 
 
86% 
(624/723) 
Mean (SD) age: 
61.54 (14.4) 
years. 
Range: 
- 
 
Mean (SD) time: 
4.6 (3.2) years 
 
Cross 
sectional 
FPAS 
18/2 
No gender differences in body image 
concerns were found, however, older 
age showed an association with an 
increased device acceptance. 
Total FPAS score: 
Mean (SD): 
78.04(17.0)  
P = 0.930 
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17 Vazquez  
(2008)(22) 
 
 
N=88. 
(0 % men) 
 
- % (-/-) Mean (SD) age: 
57.76 (15.33) 
years 
Range: 
- 
 
Mean (SD) time: 
3.1 (2.8) years  
Cross 
sectional 
FPAS but only used 
the Body Image 
Concerns scale. 
Higher body image concerns were 
associated with living in the US, being 
younger (≤ 50 years), having a history of 
non-ischemic cardiomyopathy and using 
psychotropic medication. 
Body image concerns: 
 
Means (SD) of Females by Age Group: 
Young: 25.8 (28.2) 
Middle: 11.5 (23.2) 
Older:  9.7 (20.1) 
18 Wilson 
 (2013)(57) 
N= 101. 
(66 % men) 
- % (-/-) Mean (SD) age: 
65 (12.8) years 
 
Range: 
29-88 years 
Years (%): 
< 1 y: 12 (12) 
1 ≤ 2 y:  9 (9) 
2 -5 y: 45 (45)  
> 5 y: 35 (34) 
Cross 
sectional 
FPAS Body Image Concerns 
Mean (SD): 
10.6 (22.2) 
 
Racial and Gender differences related to 
Body Image Concerns: 
Mean (SD). 
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White (n=59): 
Men: 7.0 (15.0) 
Women: 9.1 (21.0) 
Total: 7.4 (16.1) 
African American (n=42):  
Men: 8.3 (20.6) 
Women: 20.3 (32.5) 
Total: 15.2 (28.4) 
 
In particular differences between African 
American men and women were 
considerable. 
19 Wojcicka  
(2008)(60) 
N=45 
(55.7% men) 
 
 
81.8% 
(45/55) 
Mean (SD) age: 
21.2 (4.3) years 
Range: 
14-29 years 
A total of 35 
4.3 (2.7) years 
Range: 
5 months to 11 
years 
Cross-
sectional 
Purpose designed 
questionnaire: 
 
 
The implantation site was visible to most 
patients, but a majority deemed the 
appearance of the scar or bump 
acceptable. Almost half of the patients 
admitted to covering up the wound, and 
40 
 
subjects ≥18 years half had negative opinions on the scar. 
Some issues with shame, being intimate 
and being undressed were reported. 
PROSPECTIVE 
20 Carroll 
(2005) (55) 
N=59 
 
No shock group: 
N= 43 
(67.44% men) 
Shock group: 
N= 16 
(81.25% men) 
 
After 1 
year: 
84.3% 
(59/70) 
Mean (SD) age: 
 
No shock group: 
64.8(12,9) years 
 
Shock group: 
57.5(18,3) years 
 
Both groups: 
Range: 
21 – 84 years 
1 year. Prospective:1 
year follow up;  
 
Brodsky Cross 
sectional at 
follow up. 
Brodsky ICD 
Questionnaire (46/5) 
 
 
Some concerns about the size, place or 
noticeability of the device were noted by 
all patients. Specifically, patients who 
had received a shock were more likely to 
wish that the device was less rigid or in 
another position. 
No shock group: 
Mean (SD) 
6.8 (2.2) 
Shock group: 
Mean (SD) 
7.9 (2.8) 
21 Flemme8  N= 56  67.5% Mean (SD) age: After 3 and 12 Prospective/ The Patient The Wishes subscale of the Brodsky 
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(2001)(54) (75 % men) 
 
(56/83) - (-) years 
Range: 
25 – >75 years 
months 
 
 
Longitudinal 
 
Implantable 
Cardioverter 
Defibrillator 
Questionnaire of 
Brodsky. 
 
questionnaire decreased from 3 months 
to 12 months, but the change was not 
significant. 
 
Wishes after 3 months (N=54): 
Sum (range)8 
349 (216-648) 
 
Wishes after 12 months (N=53): 
Sum (range). 
339 (212-848) 
 
P = 0.504. 
22 Hegel  
(1997)(53) 
N=38 
(86 % men) 
 
 
(N= 25 
responded 
after 1 year) 
(66%) 
 
Age (SD) mean: 
62.2 (-) years (at 
time of 
implantation). 
 
4.22 (2-8) 
years 
Observational, 
longitudinal, 1 
and 2 years 
follow up 
The ICD Quality of 
Life questionnaire.  
 
Worries about body appearance did not 
decrease with time, and were not 
associated with depression, trait anxiety 
and anxiety sensitivity. 
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(N= 21 
responded 
after 2 
years) 
(55%) 
Range: 
29-78 years (at 
time of  
implantation) 
 
Appearance:  
Mean (SD): 
Baseline: 0.63(1.13) 
1 year:     0.67(1.09) 
2 year      0.62(1.02) 
 
Appearance was not associated to 
depression or anxiety.  
23 Marshall  
(2012)(23) 
N= 47. 
(70% men) 
 
67% (47/70) Mean (SD) age: 
58 (16.44) years 
 
Range: 
- 
 
  
Post 
implantation 
to 12 months 
Prospective 
study 
 
Questionnaires 
at: 
Baseline and 4, 
8 and 12 
months.  
ICD specific 
questionnaire 
adopted from Hegel 
et al 1997. 
Contains 15 items. 
 
Women worried more than men about 
their looks after receiving an ICD and 
their scores remained constant. Younger 
women worried more than older women 
at both time points. 
Men were less worried about their looks 
and their scores were significantly 
reduced over time. 
 
Worrying about looks: 
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At discharge mean scores were: 
Females: 1.07 
Males: 0.36 
(P =  0.0013) 
 
At 4 months mean scores were: 
Females: 1.07 
Males: 0.24 
(P = 0.0017) 
 
At 12 months mean scores were: 
Females: 1.21 
Males: 0.27 
(P = 0.0013) 
24 Starrenburg 
(2014)(20) 
N=300 
(82.3 % men) 
 
86.5% 
(300/347) 
Mean (SD) age: 
62.0 (11.1) years 
Range: 
- 
12 months. Prospective 
quantitative 
study. 
Questionnaires 
FPAS In the domain Body image concerns 
women had higher levels of concerns as 
compared to men and thereby gender as 
an independently association  with 
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 405 
 
 Footnotes: 
1. Comparison of Adults with Congenital Heart Disease (ACHC): ICDs, pacemakers, no devices and non-ACHD patients with ICDs. 
2-4. Mix of pacemaker and ICD patients 
5. Age and range are from the original sample of the 25 implanted recipients from 1987 – 1993. A total of 14 patients were > 18 years old. 410 
6. The population were patients with ARVD/C (Arrhytmogenic right ventricular dysplasia/cardiomyopathy) 
7. One of the exclusion criteria was age < 16 years. 
8. Statistics are reported in total summation scores, not averages.  
 prior 
implantation, 2, 
5, 8, and 12 
months post 
implantation.  
 
However results 
on FPAS are 
cross sectional 
after 1 year 
poorer device-related acceptance.  (P = 
0.043, Cohen’s effect size (ES) = 0.27) 
 
Age, type D personality, ICD indication, 
comorbidity, shocks, ejection fraction 
and age were not significantly related to 
body image. 
 
45 
 
 
 415 
 
 
 
 
  420 
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Instrument  Study  Language  Internal consistency 
(Cronbach’s alpha):  
Test-retest 
Reliability: 
Correlation 
coefficient 
Factor analysis 
   Total  
 
Body 
Image 
Concerns 
(BIC) 
  
Florida Patient Acceptance Survey 
 
Description: 
Florida Patient Acceptance Survey (FPAS) is disease 
specific to patients with implanted devices (Burns 2005). 
 
It consists of 18 items rated on a 5-point Likert scale from 
1 (strongly disagree) to 5 (strongly agree). Only 15 items 
contribute to the total score as 3 items are filler items. 
Bedair 
(2015) (47) 
English 
 
- - - - 
Birnie  
(2009) (46) 
English - - - - 
Burns(2005) 
(41) 
English α = 0.83 α   = 0.74 - 1. Return to function 
2. Device-related Distress 
3. Positive Appraisal 
4. Body Image Concerns 
Groeneveld English - - - - 
Table 3:  Questionnaires identified 
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Starrenburg (2014) used a 5-point Likert scale 0 (strongly 
disagree) to 4 (strongly agree). With a score range 0-60. 
 
It is composed of 4 consistent factors: 
- Return to Life [RTL]  - 4 items 
- Device-related distress [DRD] – 5 items  
- Positive appraisal [PA] - 4 items 
- Body Image Concerns [BIC] – 2 items  
 
A high score on DRD and BIC means less acceptance. 
A high score on RTF and PA means more acceptance.  
 
Both the total and the subscale scores range from 0–100.  
 
 
(2007) (48) 
James 
(2012) (56) 
English - - - - 
Lewis  
(2014) (50) 
English - - - - 
 
Pedersen 
(2008) (51) 
Danish α   = 
0.85 
α   = 0.73  The four factors accounted for 64.3% of 
the variance: 
Factor I (Device related distress) = 33.0% 
Factor II (Positive appraisal) = 13.8% 
Factor III (Return to function) =11.1% 
Factor IV (Body image concerns) = 6.4% 
Spindler 
(2009) (21) 
Danish -  - - - 
Starrenburg 
(2014) (20) 
Dutch -  -  -  -  
Vazquez 
(2008) (22) 
English - α   = 0.79 - - 
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Wilson 
(2013) (57) 
English  0.85 α   =0.82 - - 
 
Brodsky ICD Questionnaire Brodsky 1988 (81) 
Description: 
The questionnaire measures the concerns of ICD patients.   
It consists of 46 items rated on a 3-point Likert scale from 
1 (not at all), 2 (some) to 3 (a lot). 
 
It is composed of 8 subscales: 
- Their level of fear – 5 items 
- Embarrassment – 5 items 
- Suffering – 5 items 
- Worry about the ICD – 5 items 
- Wishes – 5 items 
- Experience with ICD – 3 items 
- Concerns regarding relationship with   
  spouse / significant other – 11 items 
- The extent of lifestyle changes – 8 items 
Carroll 
(2005) (55) 
 
Norway 
- language 
not stated 
- Subscales 
in the 
interval 
α   = 0.75 -
0.85 
- - 
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Body image concerns are present in the subscale 
“Wishes”. 
I wish the ICD were: 
A. smaller 
B. less rigid 
C. less noticeable 
D. elsewhere on my body 
E. more trustworthy 
 
Higher scores indicate more concerns about the ICD. 
Brodsky ICD Questionnaire 
Description: 
The questionnaire measures the concerns of ICD patients.  
It consists of 43 items rated on a 3-point Likert scale from 
1 (not at all), 2 (some) to 3 (a lot). 
 
It is composed of 7 subscales: 
Flemme 
(2001) (54) 
Sweden 
- language 
not stated 
- Subscales 
in the 
range  
α   = 0.76 
to 0.85 
- Factor analysis was performed within 
each statement (cumulatively varied 
between 53% and 74 % of total variance, 
factor loadings ranging 0.51-0.91). 
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- Their level of fear – 5 items 
- Embarrassment – 5 items 
- Suffering – 5 items 
- Worry about the ICD – 5 items 
- Wishes – 5 items 
- Concerns regarding relationship with   
  spouse / significant other – 11 items 
- The extent of lifestyle changes – 8 items 
 
Body image concerns are present in the subscale 
“Wishes”: 
 
I wish the ICD were: 
A. smaller 
B. less rigid 
C. less noticeable 
D. elsewhere on my body 
E. more trustworthy 
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Higher scores indicate more concerns about the ICD. 
*Flemme et al have used the Brodsky questionnaire in a 
modified version. 
 
 
 
IDAS (the Implanted Device Adjustment Scale) 
Description: 
(Beery 2005):  
 
The IDAS is a 22-item, 5-point Likert-scale from 1 (Strongly 
agree), 2 (Agree), 3 (No preference), 4 (Disagree) to 5 
(Strongly disagree). 
  
It was composed by 4 scale dimensions: 
“1. Attitude toward the device” 
“2. Body image” 
“3. Relief of symptoms” 
Beery 
(2005) (44) 
English 0.90 
N=45 
- 0.92 
N= 43 
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“4. Effective device function” 
 
Scores can range from 20 to 100. 
Higher numbers indicate poorer adjustment. 
IDAS (the Implanted Device Adjustment Scale) 
 
Description: 
(Beery 2007):  
The IDAS is a 21-item, 5-point Likert-scale  from 1 
(Strongly agree), 2 (Agree), 3 (No preference), 4 (Disagree) 
to 5 (Strongly disagree) 
 
Scores can range from 21 to 105.  
Higher numbers indicate poorer adjustment. 
 
(This is an adaption of the 2005 IDAS scale). 
Beery 
(2007)(42) 
English 0.89 - - Four subscales were described by the 
categories: 
- Fear/anxiety 
- Attitude  
- Preparation 
- Body awareness 
 
Three items were included in the Body 
awareness subscale: 
9. I do not like the way my body looks 
since I have had my device implanted 
(Item loading 0.844) 
14. I am concerned that my device will 
not work properly) (Item loading 0.369) 
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16. I am troubled by my physical 
appearance since I have had my device 
(Item loading 0.812) 
LTS (Low Treatment Satisfaction) 
 
Description: 
The LTS has 11 dichotomous items. 
Items concerning due to the ICD: 
-A mistrustful attitude 
- Low appraisal 
- A negative body image  
The total treatment satisfaction score ranged from 0 to 11 
(0 = very satisfied, 11 = most dissatisfied) and was 
markedly skewed to the right.  
 
A negative body image subscale: 
- ICD feels like a foreign body 
- Disturbed by changes of body form 
Ladwig 
(2005) 
Germany  
- language 
not stated 
0.73 - - - 
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The Cleveland Clinic AICD Psychosocial Inventory 
 
Description: 
The Psychosocial Inventory elicit information gathered 
from multiple choice questions on: 
 -Demographics 
- Medical history 
- Patient attitudes towards the device 
- Body image distortions 
- Lifestyle alterations 
-Impact on family and marriage 
- General quality of life 
- Device-specific concerns 
Pycha 
(1990) (45) 
English - - - - 
The Worries About ICDs Scale (WAICD) 
 
Description: 
The WAICD examines quality-of-life issues associated with 
having an ICD and reflects the degree to which the 
Rahmawati 
(2013) (52) 
Japanese 0.89 - - - 
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respondent experiences the problem.  
 
The WAICD is a modification of the 26-item “Index of 
Subjective Concerns for People with ICD’s” (ISCP-ICD) 
(Vitale and Funk 1995) suitable for adults. 
 
It consists of 26 items rated on a 5- point Likert scale from 
0 (not at all true), 1 (a little true), 2 (sort of true), 3 (quite 
a bit true) and to 4 (extremely true). 
 
The score is determined by the total of the 26 items, with 
a scoring range of 0 to 104.  
 
Lower scores are reflective of less worry. 
Higher scores indicate heightened worry.  
 
Body image concerns are present in the following 
questions:  
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“9. It bothers me that there is a “bump” where the ICD is.” 
“10. It bothers me that I have to wear clothes that cover 
up the place where the ICD sticks out” 
Unspecified modification of SF 36 
Description: 
The questionnaire assessed quality of life in 4 areas:(82) 
- Demographics 
- Education and work status 
- Health and exercise 
- Self-image and social interaction 
Dubin  
(1996) (58) 
English - - - - 
Purpose-designed device questionnaire 
Description: 
The questionnaire was specifically designed to assess the 
patients’ perceptions of an implanted device. 
 
It consists of 23 items rated on several scales. Some items 
were rated on a 3- point Likert scale and others on a 4-
point Likert scale – (with different answer categories) and 
Duru 
(2001) (43) 
Zürich, 
Switzerland 
 
Middlesex, 
UK 
 
- language 
not stated 
- - - - 
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some also dichotomous.  
 
Questions regarding Body image concerns: 
“5. Did the implanted device change your image of your 
body?” (yes/no) 
 
“6. To what extent do the visible changes at the 
implantation site disturb you?” (Does not disturb, To some 
degree, Considerably, Very much) 
Unspecified purpose-designed questionnaire 
Description: 
The questionnaire was subjective and experiential 
demographic and biopsychosocial and comprised of 7 
categories:  
- Psychiatric variables,  
- Patient attitudes toward the ICD and their illness,  
- ICD discharges 
- Patient-perceived family attitudes toward the ICD 
Heller  
(1998) (59) 
English - - - - 
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- Compliance variables, 6. Quality-of-life variables,  
- History and symptoms of cardiac illness). 
 
The questions were designed in a Likert scale fashion. 
Unknown number of questions in total and on body image 
concerns. 
Purpose designed questionnaire 
Description: 
In order to asses patients quality of life a questionnaire 
was developed to asses important issues and problems of 
patients with ICDs. 
It consisted of four parts. 
Part 1: Functioning of patients with ICDs (e.g. shock) 
Part 2: Various psychological problems 
Part 3: Everyday activities  
Part 4: Future plans and advantages/disadvantages of 
living with an ICD 
Unknown number of items. 
Wójcicka 
(2008) (60) 
Poland 
- language 
not stated 
- - - - 
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Some of the questions were closed questions, with 
suggested answers, i.e. yes or no, while some of the 
questions were open. 
 
Questions regarding Body image concerns: 
(Part 4) 
“The appearance of the implantation area” 
“Question about sexual life”? 
ICD specific questionnaire  
Description: 
The questionnaire is adopted from “Hegel et al 1997” with 
15 questions. In contrast to Hegel (1997) it is measured 
on a 5-point Likert scale.  
 
The questions focused on impact of the device and shock 
therapy upon: 
- Driving 
- Comfort 
Marshall 
(2012) (23) 
English - - - - 
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- Worry and anxiety 
- Physical and sexual activity 
- Sleep 
- Financial and family issues”. 
 
Higher scores indicate worse outcome. 
 
Questions regarding Body image concerns: 
“Worry about looks”. 
Reported was the Cronbach’s alpha coefficient from Hegel 
of 0.79. 
The ICD Quality of Life questionnaire 
 
Description: 
The questionnaire was purpose designed with 15 
questions measured on a 6-point Likert scale: 0 (Not at all) 
to 5 (Very much so).  
 
Hegel 
(1997)(53) 
English 0.79 - - - 
61 
 
“The questions focused on 16 variables: 
- Frequency of shock 
- The occurrence of warning signals before shock 
- The ability to prevent shock 
- The ability to control the intensity and frequency of  
   Shock 
- The ability to predict shock 
- Levels of anxiety about the occurrence of shock 
- Levels of discomfort secondary to shock 
- Interference in daily activities 
- Time spent worrying about shock 
- Interference in sexual functioning 
- Financial difficulties secondary to the ICD 
- Overprotectiveness from significant other 
- Worries about appearance with the ICD 
- Feeling like a burden to the family 
- Quality of sleep 
- Avoidance of activities secondary to the ICD”.  
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 Footnotes: 
1. Correlated item-total correlations. Abbreviation: MICC = mean inter-item correlation 
2. Items assigned to a factor are presented in bold 
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  Figure 1: PRISMA Flowchart  
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3302 references imported to Covidence August 2016 
217 additional references imported to Endnote in 
the refined updated search May 2017  
Embase (ICD & Body image) 8 
Embase (ICD & Qualitative) 89 
Medline  (ICD & Body image) 5 
Medline  (ICD & Qualitative) 83 
PsycInfo (ICD & Body image) 0 
PsycInfo (ICD & Qualitative) 8 
Cinahl  (ICD & Body image) 4 
Cinahl  (ICD & Qualitative) 20 
 
1 reference found via screening the references 
And imported to Covidence June 2017  
 
A total of 40 studies included: 
Qualitative studies N= 16 
Quantitative studies N = 24 
104 Studies excluded: 
34 Wrong outcome 
8 Duplicates 
17 Questionnaires with BIC items  
only  reporting a total score 
4 Wrong language 
30 Wrong study design 
5 Wrong device/placement   
2 Only title/abstract available 
4 Wrong population 
 
3269 studies excluded (not about body image 
concerns) 
3415 studies ready to be screened  
144 studies assessed for full-text eligibility 
3844 references imported to Endnote August 2016 
 
Embase (ICD & Body image) 52 
Embase (ICD & Qualitative) 1.175 
Medline  (ICD & Body image) 157 
Medline  (ICD & Qualitative) 2.020 
PsycInfo (ICD & Body image) 17 
PsycInfo (ICD & Qualitative) 115 
Cinahl  (ICD & Body image) 26 
Cinahl  (ICD & Qualitative) 282 
 
105 duplicates removed 
112 references imported to Covidence May 2017 
542 duplicates removed 
2 duplicates removed 
3413 screened at title/abstract level 
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